标题
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
作者
关键词
-
出版物
Vaccines
Volume 10, Issue 5, Pages 816
出版商
MDPI AG
发表日期
2022-05-21
DOI
10.3390/vaccines10050816
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
- (2021) Jiajie Hou et al. Nature Reviews Clinical Oncology
- Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
- (2021) Kanak Parmar et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations
- (2021) Linlin Guo et al. BRITISH JOURNAL OF CANCER
- Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response
- (2021) Davis W. Crews et al. Frontiers in Oncology
- Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
- (2021) Marek Z. Wojtukiewicz et al. CANCER AND METASTASIS REVIEWS
- Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
- (2021) Peter Lawrence Smith et al. Vaccines
- Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma
- (2020) Karyn Haitz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
- (2020) Jiansong Han et al. BIOMEDICINE & PHARMACOTHERAPY
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
- (2020) Patrick A. Ott et al. CELL
- HPV Vaccination and the Risk of Invasive Cervical Cancer
- (2020) Jiayao Lei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Vaccines and Cancer Immunotherapy
- (2020) Darshak Bhatt et al. Vaccines
- Vaccine-Induced CD8+ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation
- (2020) Elisabeth M. S. Beijnen et al. Frontiers in Immunology
- A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
- (2020) Qian Huang et al. Frontiers in Cell and Developmental Biology
- BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers
- (2020) Abu Salim Mustafa Vaccines
- Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers
- (2019) Jitwadee Inthagard et al. CLINICAL SCIENCE
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate Tumors
- (2019) Patrick A. Ott et al. Cancer Discovery
- Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
- (2019) James L. Gulley et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Vaccines
- (2019) Peter J. DeMaria et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Treatment of Metastatic Disease through Natural Killer Cell Modulation by Infected Cell Vaccines
- (2019) Seyedeh Raheleh Niavarani et al. Viruses-Basel
- Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety
- (2019) Steven S Raman et al. Immunotherapy
- Cancer Vaccines: Research and Applications
- (2019) Vasso Apostolopoulos Cancers
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
- (2019) Jing Zhao et al. Frontiers in Pharmacology
- Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1
- (2018) Paulo F. Severino et al. BMC CANCER
- Present status and future perspective of peptide-based vaccine therapy for urological cancer
- (2018) Wataru Obara et al. CANCER SCIENCE
- Cancer vaccines: translation from mice to human clinical trials
- (2018) Hoyoung Maeng et al. CURRENT OPINION IN IMMUNOLOGY
- Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
- (2018) Catherine E Handy et al. Future Oncology
- Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
- (2018) Janos L. Tanyi et al. Science Translational Medicine
- Immunotherapies: Exploiting the Immune System for Cancer Treatment
- (2018) Jeffrey Koury et al. Journal of Immunology Research
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Combining Adoptive Cell Therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid Skin Tumors
- (2018) Jeremy M. Grenier et al. Frontiers in Immunology
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Personalized cancer neoantigen vaccines come of age
- (2018) Yanhong Chu et al. Theranostics
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Adoptive cellular therapies: the current landscape
- (2018) Maartje W. Rohaan et al. VIRCHOWS ARCHIV
- Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
- (2018) Sandra Wagner et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
- (2018) Ren-You Pan et al. Journal of Immunology Research
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
- (2017) Margaret E. Gatti-Mays et al. Human Vaccines & Immunotherapeutics
- Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
- (2016) Marie de Charette et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers
- (2016) Claud Grigg et al. SEMINARS IN ONCOLOGY
- Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
- (2016) P. Baumgaertner et al. OncoImmunology
- Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
- (2015) F. J. Kohlhapp et al. CLINICAL CANCER RESEARCH
- Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
- (2015) D. GuhaThakurta et al. CLINICAL CANCER RESEARCH
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- NK cell-based cancer immunotherapy: from basic biology to clinical application
- (2015) Yang Li et al. Science China-Life Sciences
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Pancreatic cancer: Update on immunotherapies and algenpantucel-L
- (2015) Kinsey A. McCormick et al. Human Vaccines & Immunotherapeutics
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
- (2015) Athalia R Pyzer et al. Human Vaccines & Immunotherapeutics
- Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer
- (2014) Lawrence Fong et al. JNCI-Journal of the National Cancer Institute
- History of vaccination
- (2014) S. Plotkin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review
- (2014) Daniel M Geynisman et al. Human Vaccines & Immunotherapeutics
- Live-attenuated bacteria as a cancer vaccine vector
- (2013) Bertrand Toussaint et al. Expert Review of Vaccines
- Deciphering and Reversing Tumor Immune Suppression
- (2013) Greg T. Motz et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
- (2013) J. L. Gulley et al. Cancer Immunology Research
- Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study
- (2012) Jeffrey M. Hardacre et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Ravi A Madan et al. LANCET ONCOLOGY
- Whole Cell Vaccines—Past Progress and Future Strategies
- (2012) Bridget P. Keenan et al. SEMINARS IN ONCOLOGY
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- MAGE A3 antigen-specific cancer immunotherapeutic
- (2010) Nir Peled et al. Immunotherapy
- Adaptive immunity
- (2010) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
- (2010) V. F. Van Tendeloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment
- (2009) Thaís Helena Gasparoto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Innate immunity
- (2009) Stuart E. Turvey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started